Kageyama Ken, Ozaki Shinji, Sato Takami
Department of Diagnostic and Interventional Radiology, Osaka City University Graduate School of Medicine; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University.
Department of Surgery, National Hospital Organization, Kure Medical Cancer Center; Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University.
J Vis Exp. 2019 Nov 6(153). doi: 10.3791/59941.
In recent decades, subcutaneously implanted patient-derived xenograft tumors or cultured human cell lines have been increasingly recognized as more representative models to study human cancers in immunodeficient mice than traditional established human cell lines in vitro. Recently, orthotopically implanted patient-derived tumor xenograft (PDX) models in mice have been developed to better replicate features of patient tumors. A liver orthotopic xenograft mouse model is expected to be a useful cancer research platform, providing insights into tumor biology and drug therapy. However, liver orthotopic tumor implantation is generally complicated. Here we describe our protocols for the orthotopic implantation of patient-derived liver-metastatic uveal melanoma tumors. We cultured human liver metastatic uveal melanoma cell lines into immunodeficient mice. The protocols can result in consistently high technical success rates using either a surgical orthotopic implantation technique with chunks of patient-derived uveal melanoma tumor or a needle injection technique with cultured human cell line. We also describe protocols for CT scanning to detect interior liver tumors and for re-implantation techniques using cryopreserved tumors to achieve re-engraftment. Together, these protocols provide a better platform for liver orthotopic tumor mouse models of liver metastatic uveal melanoma in translational research.
近几十年来,皮下植入的患者来源异种移植肿瘤或培养的人类细胞系,相较于传统的体外建立的人类细胞系,在免疫缺陷小鼠中越来越被认为是研究人类癌症更具代表性的模型。最近,已开发出小鼠原位植入患者来源肿瘤异种移植(PDX)模型,以更好地复制患者肿瘤的特征。肝脏原位异种移植小鼠模型有望成为一个有用的癌症研究平台,为肿瘤生物学和药物治疗提供见解。然而,肝脏原位肿瘤植入通常很复杂。在此,我们描述了我们将患者来源的肝转移性葡萄膜黑色素瘤肿瘤原位植入的方案。我们将人类肝转移性葡萄膜黑色素瘤细胞系培养到免疫缺陷小鼠体内。使用患者来源的葡萄膜黑色素瘤肿瘤块的手术原位植入技术或培养的人类细胞系的针注射技术,这些方案可始终获得较高的技术成功率。我们还描述了用于检测肝脏内部肿瘤的CT扫描方案以及使用冷冻保存的肿瘤实现再植入的再植入技术方案。总之,这些方案为肝转移性葡萄膜黑色素瘤的肝脏原位肿瘤小鼠模型在转化研究中提供了一个更好的平台。
Microvasc Res. 2002-9
Melanoma Res. 2023-2-1
Invest Ophthalmol Vis Sci. 2007-7
Ann Eye Sci. 2022-3
Ocul Oncol Pathol. 2018-4
Clin Ophthalmol. 2017-1-31